Muirden KD - Search Results

1

Clinical, laboratory and genetic markers associated with erosions and remission in patients with early inflammatory arthritis: a prospective cohort study.

Stockman A, Tait BD, Wolfe R, Brand CA, Rowley MJ, Varney MD, Buchbinder R, Muirden KD. Stockman A, et al. Among authors: muirden kd. Rheumatol Int. 2006 Apr;26(6):500-9. doi: 10.1007/s00296-005-0027-x. Epub 2005 Sep 7. Rheumatol Int. 2006. PMID: 16151812

2

Relationship of progression of radiographic changes in hands and wrists, clinical features and HLA-DR antigens in rheumatoid arthritis.

Stockman A, Emery P, Doyle T, Hopper J, Tait B, Muirden K. Stockman A, et al. J Rheumatol. 1991 Jul;18(7):1001-7. J Rheumatol. 1991. PMID: 1920304

3

Activity of rheumatoid arthritis and levels of collagen antibodies: a prospective study.

Stockman A, Rowley MJ, Emery P, Muirden KD. Stockman A, et al. Among authors: muirden kd. Rheumatol Int. 1989;8(6):239-43. doi: 10.1007/BF00270978. Rheumatol Int. 1989. PMID: 2727549

4

Specificity of antibodies to type II collagen in early rheumatoid arthritis.

Cook AD, Rowley MJ, Stockman A, Muirden KD, Mackay IR. Cook AD, et al. Among authors: muirden kd. J Rheumatol. 1994 Jul;21(7):1186-91. J Rheumatol. 1994. PMID: 7525955

5

The effect of HLA-DRB1 disease susceptibility markers on the expression of RA.

Rowley MJ, Stockman A, Brand CA, Tait BD, Rowley GL, Sherritt MA, Mackay IR, Muirden KD, Bernard CC. Rowley MJ, et al. Among authors: muirden kd. Scand J Rheumatol. 1997;26(6):448-55. doi: 10.3109/03009749709065718. Scand J Rheumatol. 1997. PMID: 9433406

6

Antibodies to type II collagen and HLA disease susceptibility markers in rheumatoid arthritis.

Cook AD, Stockman A, Brand CA, Tait BD, Mackay IR, Muirden KD, Bernard CC, Rowley MJ. Cook AD, et al. Among authors: muirden kd. Arthritis Rheum. 1999 Dec;42(12):2569-76. doi: 10.1002/1529-0131(199912)42:12<2569::AID-ANR9>3.0.CO;2-3. Arthritis Rheum. 1999. PMID: 10616002 Free article.

7

Coexistent rheumatoid arthritis and systemic lupus erythematosus: clinical, serological, and phenotypic features.

Brand CA, Rowley MJ, Tait BD, Muirden KD, Whittingham SF. Brand CA, et al. Among authors: muirden kd. Ann Rheum Dis. 1992 Feb;51(2):173-6. doi: 10.1136/ard.51.2.173. Ann Rheum Dis. 1992. PMID: 1550399 Free PMC article.

8

Immunosusceptibility genes in rheumatoid arthritis.

Sherritt MA, Tait B, Varney M, Kanaan C, Stockman A, Mackay IR, Muirden K, Bernard CC, Rowley MJ. Sherritt MA, et al. Hum Immunol. 1996 Nov;51(1):32-40. doi: 10.1016/s0198-8859(96)00204-2. Hum Immunol. 1996. PMID: 8911995

9

Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.

Stockman A, Zilko PJ, Major GA, Tait BD, Property DN, Mathews JD, Hannah MC, McCluskey J, Muirden KD. Stockman A, et al. Among authors: muirden kd. J Rheumatol. 1986 Apr;13(2):269-73. J Rheumatol. 1986. PMID: 3459889

10

Clinical rheumatoid vasculitis associated with the B8 DR3 phenotype.

Cunningham TJ, Tait BD, Mathews JD, Muirden KD. Cunningham TJ, et al. Among authors: muirden kd. Rheumatol Int. 1982;2(3):137-9. doi: 10.1007/BF00541167. Rheumatol Int. 1982. PMID: 6984537

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

117 results

Search Page